EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Reduced Circulating MOTS-c Levels in Hashimoto’s Thyroiditis Reflect Integrated Autoimmune and Metabolic Dysregulation: A Cross-Sectional Study

Hanişe Ozkan Sonay, Eda Nur Duran iD, Murvet Algemi iD, Berrak Sahtiyanci, Irem Kirac Utku, Esra Çokiçli, Naile Fevziye Misirlioglu iD, Gonul Simsek, Hafize Uzun iD, Omur Tabak

Journal of Clinical Medicine · 22.05.2026 · 15 (11) · 4002

DOI: 10.3390/jcm15114002 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 22.05.2026. Verfasst von Hanişe Ozkan Sonay und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Kanuni Sultan Suleyman Training and Research Hospital, Health Sciences University, 34303 Istanbul, Türkiye. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hashimoto’s thyroiditis (HT) is a common autoimmune disorder characterized by chronic inflammation and metabolic alterations. Mitochondria-derived peptides (MDPs), particularly mitochondrial open-reading frame of the 12S rRNA-c (MOTS-c), have emerged as key regulators of cellular metabolism, insulin sensitivity, oxidative stress, and inflammatory responses. This study aimed to investigate the association between circulating MOTS-c levels and HT and to explore its potential role in thyroid autoimmunity and metabolic regulation.

Methods

In this cross-sectional study, patients diagnosed with HT (n: 90) were compared with age- and sex-matched healthy controls (n: 90).

Results

A total of 180 participants were included, comprising 90 patients with HT and 90 age- and sex-matched healthy controls. Circulating MOTS-c levels were significantly lower in patients with HT compared to controls (p < 0.001). MOTS-c levels demonstrated significant inverse correlations with body mass index, fasting glucose, HbA1c, HOMA-IR, thyroid-stimulating hormone, C-reactive protein, and thyroid autoantibody levels (all p < 0.05). In subgroup analyses, these associations remained significant within the HT cohort, particularly for HOMA-IR and thyroid autoantibodies. Multivariable regression analysis identified HT (β = −30.04, p < 0.001) and HOMA-IR (β = −0.85, p < 0.001) as independent determinants of reduced circulating MOTS-c levels. Levothyroxine (LT4) use was not associated with significant differences in MOTS-c concentrations.

Conclusions

Circulating MOTS-c levels are markedly reduced in patients with HT and are independently associated with insulin resistance and autoimmune burden. These findings suggest that impaired mitochondrial signaling may play a role in the pathophysiology of thyroid autoimmunity and highlight MOTS-c as a promising biomarker linking metabolic dysfunction and immune dysregulation.

Schlagwörter

Stichwörter der Autor:innen

Hashimoto’s thyroiditisMOTS-cautoimmune thyroid diseaseimmuno-metabolismmitochondria-derived peptidesmitochondrial dysfunction

Autor:innen und Institutionen

  • Department of Internal Medicine, Kanuni Sultan Suleyman Training and Research Hospital, Health Sciences University, 34303 Istanbul, Türkiye.
  • Department of Internal Medicine, Pervari State Hospital, 56700 Siirt, Türkiye.
  • Department of Clinical Biochemistry, Kanuni Sultan Suleyman Training and Research Hospital, Health Sciences University, 34303 Istanbul, Türkiye.
  • Department of Internal Medicine, Istanbul Physical Therapy and Rehabilitation Training and Research Hospital, Health Sciences University, 34303 Istanbul, Türkiye.
  • Department of Internal Medicine, Division of Geriatrics, Tekirdağ Dr. İsmail Fehmi Cumalıoğlu City Hospital, 59030 Tekirdağ, Türkiye.
  • Department of Internal Medicine, Faculty of Medicine, Istanbul Medipol University, 34810 Istanbul, Türkiye.

ORCID-Profile: Eda Nur Duran, Murvet Algemi, Naile Fevziye Misirlioglu, Hafize Uzun

Zitieren

APA

Sonay, H. O., Duran, E. N., Algemi, M., Sahtiyanci, B., Utku, I. K., Çokiçli, E., Misirlioglu, N. F., Simsek, G., Uzun, H., & Tabak, O. (2026). Reduced Circulating MOTS-c Levels in Hashimoto’s Thyroiditis Reflect Integrated Autoimmune and Metabolic Dysregulation: A Cross-Sectional Study. Journal of Clinical Medicine, 15(11), 4002. https://doi.org/10.3390/jcm15114002

Vancouver

Sonay HO, Duran EN, Algemi M, Sahtiyanci B, Utku IK, Çokiçli E, et al. Reduced Circulating MOTS-c Levels in Hashimoto’s Thyroiditis Reflect Integrated Autoimmune and Metabolic Dysregulation: A Cross-Sectional Study. Journal of Clinical Medicine. 2026;15(11):4002. doi:10.3390/jcm15114002

BibTeX
@article{Sonay2026,
  author = {Sonay, Hanişe Ozkan and Duran, Eda Nur and Algemi, Murvet and Sahtiyanci, Berrak and Utku, Irem Kirac and Çokiçli, Esra and Misirlioglu, Naile Fevziye and Simsek, Gonul and Uzun, Hafize and Tabak, Omur},
  title = {Reduced Circulating MOTS-c Levels in Hashimoto’s Thyroiditis Reflect Integrated Autoimmune and Metabolic Dysregulation: A Cross-Sectional Study},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {11},
  pages = {4002},
  doi = {10.3390/jcm15114002}
}
Kostenlos starten →